{"disease":{"id":"to-evaluate-the-safety-and-efficacy-of-celecoxib-plus-nucleos-t-ide-analogues-in-nucleos-t-ide-treated-patients-with-chronic-hepatitis-b","name":"to evaluate the safety and efficacy of celecoxib plus nucleos t ide analogues in nucleos t ide treated patients with chronic hepatitis b"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05256823","title":"Safety and Efficacy of Celecoxib Plus Nucleos(t)Ide Analogues on the Hepatitis B Surface Antigen of Virally Suppressed Subjects With Chronic Hepatitis B","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":47,"lead_sponsor_name":"Lai Wei","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}